1-4 of 4
Ye Tan, Ms
Close
Sort by
Journal Articles

Hematopoietic Cell Transplantation as Therapy for Pediatric Patients with Isolated CNS Relapse.

Paul Harker-Murray, MD, PhD, Jakub Tolar, MD, PhD, Ye Tan, MS, Margaret L. MacMillan, MD, John Wagner, MD, Paul J. Orchard, MD
Journal: Blood
Blood (2005) 106 (11): 2745.
https://doi.org/10.1182/blood.V106.11.2745.2745
Published: 2005
Journal Articles

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

Pamala A. Jacobson, PharmD, John Rogosheske, PharmD, Kathleen Green, PharmD, Claudio Brunstein, MD, Juliet Barker, MD, Jeff Miller, MD, John Wagner, MD, Philip McGlave, MD, Ye Tan, MS, Daniel Weisdorf, MD
Journal: Blood
Blood (2005) 106 (11): 3673.
https://doi.org/10.1182/blood.V106.11.3673.3673
Published: 2005
Journal Articles

Prognostic Factors in Patients with Fanconi Anemia (FA) after Alternate Donor (AD) Hematopoietic Cell Transplantation (HCT).

Suleimman A. Alsweedan, MD, John E. Wagner, MD, Ye Tan, Ms, Todd E. DeFor, Ms, Margaret L. MacMillan, MD
Journal: Blood
Blood (2005) 106 (11): 564.
https://doi.org/10.1182/blood.V106.11.564.564
Published: 2005
Journal Articles

Negative Impact of KIR-Ligand Mismatch on Transplant-Related Mortality (TRM) in Umbilical Cord Blood Transplant (UCBT) Recipients.

Claudio G. Brunstein, MD, PhD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Juliet N. Barker, MD, Hariet Noreen, Ye Tan, MS, Martin Maiers, MD, Michael R. Verneris, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2005) 106 (11): 2041.
https://doi.org/10.1182/blood.V106.11.2041.2041
Published: 2005